Atrophy of the Cholinergic Basal Forebrain can Detect Presynaptic Cholinergic Loss in Parkinson's Disease
Authors:
Open Access
- 24 January 2023
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 93 (5) , 991-998
Abstract
Objectives: Structural imaging of the cholinergic basal forebrain may provide a biomarker for cholinergic system integrity that can be used in motor and non‐motor outcome studies in Parkinson's disease. However, no prior studies have validated these structural metrics with cholinergic nerve terminal in vivo imaging in Parkinson's disease. Here, we correlate cholinergic basal forebrain morphometry with the topography of vesicular acetylcholine transporter in a large Parkinson's sample.Methods: [18F]‐Fluoroethoxybenzovesamicol vesicular acetylcholine transporter positron emission tomography was carried out in 101 non‐demented people with Parkinson's (76.24% male, mean age 67.6 ± 7.72 years, disease duration 5.7 ± 4.4 years). Subregional cholinergic basal forebrain volumes were measured using magnetic resonance imaging morphometry. Relationships were assessed via volume‐of‐interest based correlation analysis.Results: Subregional volumes of the cholinergic basal forebrain predicted cholinergic nerve terminal loss, with most robust correlations occurring between the posterior cholinergic basal forebrain and temporofrontal, insula, cingulum, and hippocampal regions, and with modest correlations in parieto‐occipital regions. Hippocampal correlations were not limited to the cholinergic basal forebrain subregion Ch1‐2. Correlations were also observed in the striatum, thalamus, and brainstem.Interpretation: Cholinergic basal forebrain morphometry is a robust predictor of regional cerebral vesicular acetylcholine transporter bindings, especially in the anterior brain. The relative lack of correlation between parieto‐occipital binding and basal forebrain volumes may reflect the presence of more diffuse synaptopathy in the posterior cortex due to etiologies that extend well beyond the cholinergic system. ANN NEUROL 2023;93:991–998Keywords
Funding Information
- U.S. Department of Veterans Affairs (I01 RX003397)
- Michael J. Fox Foundation for Parkinson's Research
- National Institutes of Health (R01 AG073100, P50 NS123067, P50 NS091856, RO1 NS070856, P01NS015655)
This publication has 38 references indexed in Scilit:
- Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal StudyJournal of Nuclear Medicine, 2011
- Highlighting the versatility of the tracerlab synthesis modules. Part 1: fully automated production of [18F]labelled radiopharmaceuticals using a Tracerlab FXFNJournal of Labelled Compounds and Radiopharmaceuticals, 2011
- A fast diffeomorphic image registration algorithmNeuroImage, 2007
- Positron Emission Tomography of Monoaminergic Vesicular Binding in Aging and Parkinson DiseaseJournal of Cerebral Blood Flow & Metabolism, 2006
- Ageing and neuronal vulnerabilityNature Reviews Neuroscience, 2006
- Cholinergic innervation of the human thalamus: Dual origin and differential nuclear distributionJournal of Comparative Neurology, 1992
- Measurement of Radiotracer Concentration in Brain Gray Matter Using Positron Emission Tomography: MRI-Based Correction for Partial Volume EffectsJournal of Cerebral Blood Flow & Metabolism, 1992
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1985
- A HITHERTO UNDIFFERENTIATED NUCLEUS IN THE FOREBRAIN (NUCLEUS SUBPUTAMINALIS)Brain, 1915